These observations support the concept that the abnormal expression of sPmel17 and FHL2 in the epidermis is involved in the pathogenesis of vitiligo and that active interactions of sPmel17 and FHL2 are required for vitiligo repigmentation. The gene discussed is FHL2; the disease is vitiligo.